Silence Therapeutics plc (SLN)

Silence Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	61.95	54.03	54.82	73.54	27.45	13.52
Short-Term Investments	67.04	-	16.33	-	10	20
Cash & Short-Term Investments	128.99	54.03	71.14	73.54	37.45	33.52
Cash Growth	119.33%	-24.05%	-3.25%	96.37%	11.73%	26.30%
Accounts Receivable	0.29	0.23	0.92	0.33	29.31	0
Other Receivables	16.27	18.61	16.43	8.16	4.21	3.51
Receivables	16.56	18.83	17.34	8.49	33.52	3.52
Prepaid Expenses	-	8.16	8.2	4.31	3.94	0.43
Other Current Assets	11.96	-	-	-	1.49	-
Total Current Assets	157.51	81.02	96.69	86.33	76.4	37.47
Property, Plant & Equipment	1.65	1.81	2.2	1.94	1.13	0.61
Long-Term Investments	0.28	0.28	0.28	0.3	0.3	0.28
Goodwill	7.54	7.84	8.01	7.59	8.13	7.69
Other Intangible Assets	0.26	0.28	0.32	0.02	0.02	0.03
Other Long-Term Assets	2.14	2.58	-	-	-	-
Total Assets	169.38	93.82	107.5	96.19	85.97	46.08
Accounts Payable	14.27	2.63	3.19	4.07	2.29	1.79
Accrued Expenses	-	9.43	8.86	6.53	5.91	5.1
Current Portion of Leases	0.14	0.18	0.45	0.14	0.34	0.29
Current Income Taxes Payable	-	0.37	0.59	0.19	-	-
Current Unearned Revenue	2.5	5.16	8.86	4.25	17.04	2.48
Total Current Liabilities	16.91	17.77	21.94	15.17	25.58	9.65
Long-Term Leases	-	0.09	-	-	-	-
Long-Term Unearned Revenue	57.96	58.91	63.49	72.5	51.34	15.52
Total Liabilities	74.87	76.77	85.43	87.67	76.91	25.17
Common Stock	7.08	5.94	5.39	4.49	4.17	3.92
Additional Paid-In Capital	362.83	251.45	226.67	184.33	153.73	138.15
Retained Earnings	-346.65	-304.61	-263.26	-222.97	-184.22	-152
Comprehensive Income & Other	71.25	64.27	53.28	42.67	35.38	30.84
Shareholders' Equity	94.52	17.05	22.07	8.53	9.06	20.91
Total Liabilities & Equity	169.38	93.82	107.5	96.19	85.97	46.08
Total Debt	0.14	0.27	0.45	0.14	0.34	0.29
Net Cash (Debt)	128.85	53.76	70.7	73.4	37.11	33.23
Net Cash Growth	120.27%	-23.96%	-3.68%	97.80%	11.67%	25.22%
Net Cash Per Share	2.92	1.45	2.20	2.48	1.36	1.33
Filing Date Shares Outstanding	47.21	46.5	35.95	29.93	27.77	26.12
Total Common Shares Outstanding	47.21	39.62	35.94	29.93	27.77	26.12
Working Capital	140.6	63.25	74.74	71.17	50.82	27.81
Book Value Per Share	2.00	0.43	0.61	0.28	0.33	0.80
Tangible Book Value	86.72	8.93	13.74	0.91	0.92	13.18
Tangible Book Value Per Share	1.84	0.23	0.38	0.03	0.03	0.50
Machinery	-	5.06	4.99	5.11	4.07	3.4

Source: S&P Capital IQ. Standard template. Financial Sources.